{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:50:28Z","timestamp":1787849428039,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-023-04300-7","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T17:02:48Z","timestamp":1675530168000},"page":"767-776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study"],"prefix":"10.1007","volume":"41","author":[{"given":"Yukio","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-7241","authenticated-orcid":false,"given":"Tohru","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimpei","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketo","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyo","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hikatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motofumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Nishimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,4]]},"reference":[{"key":"4300_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","volume":"79","author":"M Roupr\u00eat","year":"2021","unstructured":"Roupr\u00eat M, Babjuk M, Burger M et al (2021) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol 79:62\u201379","journal-title":"Eur Urol"},{"key":"4300_CR2","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/cncr.22970","volume":"110","author":"G Novara","year":"2007","unstructured":"Novara G, De Marco V, Gottardo F et al (2007) Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 110:1715\u20131722","journal-title":"Cancer"},{"key":"4300_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis V, Shariat SF, Matin SF et al (2009) The Upper Tract Urothelial Carcinoma Collaboration. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115:1224\u20131233","journal-title":"Cancer"},{"key":"4300_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.eururo.2014.08.003","volume":"67","author":"G Ploussard","year":"2015","unstructured":"Ploussard G, Xylinas E, Lotan Y et al (2015) Conditional survival after radical nephroureterectomy for upper tract carcinoma. Eur Urol 67:803\u2013812","journal-title":"Eur Urol"},{"key":"4300_CR5","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1002\/cncr.25050","volume":"116","author":"SF Matin","year":"2010","unstructured":"Matin SF, Margulis V, Kamat A et al (2010) Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer 116:3127\u20133134","journal-title":"Cancer"},{"key":"4300_CR6","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00345-017-2032-6","volume":"35","author":"T Nakagawa","year":"2017","unstructured":"Nakagawa T, Komemushi Y, Kawai T et al (2017) Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study. World J Urol 35:1569\u20131575","journal-title":"World J Urol"},{"key":"4300_CR7","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1200\/JCO.2016.69.4141","volume":"35","author":"T Seisen","year":"2017","unstructured":"Seisen T, Krasnow RE, Bellmunt J et al (2017) Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and\/or positive regional lymph node upper tract urothelial carcinoma. J Clin Oncol 35:852\u2013860","journal-title":"J Clin Oncol"},{"key":"4300_CR8","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/JU.0000000000000644","volume":"203","author":"V Margulis","year":"2020","unstructured":"Margulis V, Puligandla M, Trabulsi EJ et al (2020) Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma. J Urol 203:690\u2013698","journal-title":"J Urol"},{"key":"4300_CR9","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","volume":"395","author":"A Birtle","year":"2020","unstructured":"Birtle A, Johnson M, Chester J et al (2020) Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet 395:1268\u20131277","journal-title":"Lancet"},{"key":"4300_CR10","unstructured":"European Association of Urology, Oncology Guidelines, Upper Urinary Tract Urothelial Cell Carcinoma. https:\/\/uroweb.org\/guidelines\/upper-urinary-tract-urothelial-cell-carcinoma. Accessed 13 Mar 2022."},{"key":"4300_CR11","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Bladder Cancer. version 1. 2022. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bladder.pdf. Accessed 13 Mar 2022."},{"key":"4300_CR12","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1002\/cncr.25043","volume":"116","author":"BR Lane","year":"2010","unstructured":"Lane BR, Smith AK, Larson BT et al (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116:2967\u20132973","journal-title":"Cancer"},{"key":"4300_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.eururo.2010.06.029","volume":"58","author":"MG Kaag","year":"2010","unstructured":"Kaag MG, O\u2019Malley RL, O\u2019Malley P et al (2010) Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 58:581\u2013587","journal-title":"Eur Urol"},{"key":"4300_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1464-410X.2012.11649.x","volume":"112","author":"E Xylinas","year":"2013","unstructured":"Xylinas E, Rink M, Margulis V et al (2013) Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int 112:453\u2013461","journal-title":"BJU Int"},{"key":"4300_CR15","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/jjco\/hyab081","volume":"51","author":"Y Yamada","year":"2021","unstructured":"Yamada Y, Nakagawa T, Miyakawa J et al (2021) Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study. Jpn J Clin Oncol 51:1577\u20131586","journal-title":"Jpn J Clin Oncol"},{"key":"4300_CR16","volume-title":"TNM classification of malignant tumours","author":"JD Brierley","year":"2017","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours, 8th edn. Wiley-Blackwell, Oxford","edition":"8"},{"key":"4300_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK (2017) AJCC cancer staging manual. Springer, New York"},{"key":"4300_CR18","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1002\/cncr.10609","volume":"94","author":"K Yoshimura","year":"2002","unstructured":"Yoshimura K, Arai Y, Fujimoto H et al (2002) Prognostic impact of extensive parenchymal invasion pattern in pT3 renal pelvic transitional cell carcinoma. Cancer 94:3150\u20133156","journal-title":"Cancer"},{"key":"4300_CR19","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/j.1365-2559.2012.04183.x","volume":"61","author":"N Sassa","year":"2012","unstructured":"Sassa N, Tsuzuki T, Fukatsu A et al (2012) Is pT3 urothelial carcinoma of the renal pelvis a homogeneous disease entity? Proposal for a new subcategory of the pT3 classification. Histopathology 61:620\u2013628","journal-title":"Histopathology"},{"key":"4300_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.eururo.2012.01.019","volume":"62","author":"SF Shariat","year":"2012","unstructured":"Shariat SF, Zigeuner R, Rink M et al (2012) Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. Eur Urol 62:224\u2013231","journal-title":"Eur Urol"},{"key":"4300_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00345-013-1073-8","volume":"32","author":"J Park","year":"2014","unstructured":"Park J, Park S, Song C et al (2014) Peripelvic\/periureteral fat invasion is independently associated with worse prognosis in pT3 upper tract urothelial carcinoma. World J Urol 32:157\u2013163","journal-title":"World J Urol"},{"key":"4300_CR22","volume-title":"Pathology and genetics of tumours of the urinary system and male genital organs","author":"J Eble","year":"2004","unstructured":"Eble J, Sauter G, Epstein J (2004) World Health Organization classification of tumours. In: Kleihues P, Sobin LH (eds) Pathology and genetics of tumours of the urinary system and male genital organs, vol 7. IARC Press, Lyon"},{"key":"4300_CR23","volume-title":"Histological typing of urinary bladder tumours","year":"1973","unstructured":"Mostofi FK, Sobin LH, Torloni H (eds) (1973) Histological typing of urinary bladder tumours. World Health Organization, Geneva"},{"key":"4300_CR24","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982\u2013992","journal-title":"Am J Kidney Dis"},{"key":"4300_CR25","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.juro.2014.04.001","volume":"192","author":"J Park","year":"2014","unstructured":"Park J, Habuchi T, Arai Y et al (2014) Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems. J Urol 192:1064\u20131071","journal-title":"J Urol"},{"key":"4300_CR26","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.euf.2020.10.004","volume":"7","author":"T Seisen","year":"2021","unstructured":"Seisen T, Mari A, Campi R et al (2021) Prognostic impact of pT3 subclassification in a multicentre cohort of patients with urothelial carcinoma of the renal pelvicalyceal system undergoing radical nephroureterectomy: a propensity score-weighted analysis after central pathology review. Eur Urol Focus 7:1075\u20131083","journal-title":"Eur Urol Focus"},{"key":"4300_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.humpath.2016.12.009","volume":"61","author":"EM Tretter","year":"2017","unstructured":"Tretter EM, Ebel JJ, Pohar KS, Zynger DL (2017) Does the gross prosector impact pT3 subclassification or lymph node counts in bladder cancer? Hum Pathol 61:190\u2013198","journal-title":"Hum Pathol"},{"key":"4300_CR28","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/j.1464-410X.2009.08838.x","volume":"104","author":"P Colin","year":"2009","unstructured":"Colin P, Koenig P, Ouzzane A et al (2009) Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 104:1436\u20131440","journal-title":"BJU Int"},{"key":"4300_CR29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.eururo.2017.05.048","volume":"72","author":"TJ Moss","year":"2017","unstructured":"Moss TJ, Qi Y, Xi L et al (2017) Comprehensive genomic characterization of upper tract urothelial carcinoma. Eur Urol 72:641\u2013649","journal-title":"Eur Urol"},{"key":"4300_CR30","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ccell.2021.05.008","volume":"39","author":"Y Fujii","year":"2021","unstructured":"Fujii Y, Sato Y, Suzuki H et al (2021) Molecular classification and diagnostics of upper urinary tract urothelial carcinoma. Cancer Cell 39:793-809.e8","journal-title":"Cancer Cell"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04300-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-023-04300-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04300-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T10:04:06Z","timestamp":1680948246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-023-04300-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,4]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["4300"],"URL":"https:\/\/doi.org\/10.1007\/s00345-023-04300-7","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,4]]},"assertion":[{"value":"12 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All ethical standards were ensured.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}